CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −13,272 | $22.22 | $295K | 121,792 |
| 2026-09-04 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −24,799 | $22.22 | $551K | 177,184 |
| 2026-09-04 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −22,025 | $22.22 | $489K | 115,519 |
| 2026-09-04 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −21,423 | $22.22 | $476K | 203,900 |
| 2026-07-28 | SEVERINO MICHAEL Chief Executive Officer | Grant or award | +756,104 | 756,104 | ||
| 2026-07-28 | SEVERINO MICHAEL Chief Executive Officer | Grant or award · Stock Options (right to buy) | +2,224,342 | 2,224,342 | ||
| 2026-06-04 | Boor Kathryn Jean Director | Grant or award | +16,875 | 25,138 | ||
| 2026-06-04 | Mayo Stephen Director | Grant or award | +16,875 | 18,640 | ||
| 2026-06-04 | Wigzell Hans Lennart Rudolf Director | Grant or award | +16,875 | 42,098 | ||
| 2026-06-04 | BEHRENS M KATHLEEN Director | Grant or award | +16,875 | 214,357 | ||
| 2026-06-04 | Connelly Deirdre P Director | Grant or award | +16,875 | 22,100 | ||
| 2026-06-04 | Nicaise Claude Director | Grant or award | +16,875 | 48,407 | ||
| 2026-06-04 | Chambers Michael Andrew Director | Grant or award | +16,875 | 27,535 | ||
| 2026-06-04 | Barry Richard Director | Grant or award | +16,875 | 2,983,542 | ||
| 2026-03-12 | Mayo Stephen Director | Sale | −7,239 | $17.02 | $123K | 1,765 |
| 2026-03-11 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −1,097 | $17.03 | $19K | 201,983 |
| 2026-03-11 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −256 | $17.03 | $4K | 135,064 |
| 2026-03-11 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −948 | $17.03 | $16K | 225,323 |
| 2026-03-11 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −974 | $17.03 | $17K | 137,544 |
| 2026-03-09 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −162 | $16.95 | $3K | 135,433 |
Page 1 of 12 · 227 trades